Heartflow is investing in three new clinical trials to expand its product indications to high-risk asymptomatic populations. This initiative will generate significant clinical data, creating a need for data management (EDC/CTMS), analysis, and regulatory submission software and services.
Filing excerpt
In the future, we expect to begin enrollment in three randomized clinical trials focused on high-risk asymptomatic sub populations to expand the addressable market for our products.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10kdataInvestmentGet every 10-K signal for HeartFlow and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at HeartFlow this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c2cc1e7d-2d66-4d7b-88ca-32b4a0612066 returns this record as JSON. POST /v1/companies/enrich returns every signal for heartflow.com.
{
"signal_id": "c2cc1e7d-2d66-4d7b-88ca-32b4a0612066",
"signal_type": "sec-10k",
"signal_subtype": "dataInvestment",
"detected_at": "2026-03-24T05:57:57.891+00:00",
"company": {
"name": "HeartFlow",
"domain": "heartflow.com"
},
"data": {
"detail": "Heartflow is investing in three new clinical trials to expand its product indications to high-risk asymptomatic populations. This initiative will generate significant clinical data, creating a need for data management (EDC/CTMS), analysis, and regulatory submission software and services.",
"metrics": {
"timeframe": "next_year"
},
"summary": "Planning to launch three new randomized clinical trials to expand into new markets.",
"excerpts": "In the future, we expect to begin enrollment in three randomized clinical trials focused on high-risk asymptomatic sub populations to expand the addressable market for our products.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1464521/000146452126000042/htfl-20251231x10k.htm",
"filing_date": "2026-03-18",
"filing_year": 2026,
"sales_relevance": "Target for data vendors",
"signal_category": "technology"
}
}
curl https://signals.autobound.ai/v1/signals/c2cc1e7d-2d66-4d7b-88ca-32b4a0612066 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"heartflow.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.